Advertisement

Body mass index as a prognostic factor in organophosphate-poisoned patients

Published:April 21, 2014DOI:https://doi.org/10.1016/j.ajem.2014.04.030

      Abstract

      Organophosphate poisoning is a serious clinical entity and considerable morbidity and mortality. Several factors have been identified to predict outcomes of organophosphate poisoning. Organophosphates are lipophilic and therefore predicted to have a large volume of distribution and to rapidly distribute into tissue and fat. Thus, toxic effects of organophosphate would be expected to last longer in obese patients. We investigated the relationship between obesity and clinical course in 112 acute organophosphate-poisoned patients from an initial medical record review of 234 patients. One hundred twenty-two patients were excluded: 6 were children, 14 had an uncertain history of exposure and of uncertain agent, 10 were transferred to another hospital, 67 were discharged from the emergency department because their toxicity was mild, 21 had carbamate poisoning, and 4 did not have height or weight checked. Clinical features, body mass index, Glasgow Coma Scale, laboratory findings, serum cholinesterase activity, electrocardiogram finding, management, and outcomes were examined. The lipid solubility of the implicated organophosphate was characterized by its octanol/water coefficient. Forty of 112 patients were obese. Obese patients who were poisoned by high lipophilicity organophosphate compounds had a need for longer use of mechanical ventilation, intensive care unit care, and total length of admission. Body mass index can provide a guide to physicians in predicting clinical course and management in organophosphate-poisoned patients.
      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ahn J.M.
        • Nam K.B.
        • Lim J.W.
        • et al.
        Marked prolongation of QT interval and complete heart block caused by organophosphate poisoning.
        J Korean Soc Emerg Med. 2006; 70: S216-S219
        • Nelson L.S.
        • Lewin N.A.
        • Howland M.A.
        • et al.
        Goldfrank's toxicologic emergencies.
        9th ed. McGraw Hill, 2011: 1450-1466
        • Kim K.W.
        • Yoon S.K.
        • Jung Y.S.
        • et al.
        Organophosphate pesticides. Clinical toxicology.
        1st ed. Koon Ja, Seoul2006: 182-207
        • Thiermann H.
        • Eyer F.
        • Felgenhauer N.
        • et al.
        Pharmacokinetics of obidoxime in patients poisoned with organophosphorus compounds.
        Toxicol Lett. 2010; 197 ([Epub 2010 Jun 11]): 236-242
        • Gunnell D.
        • Eddleston M.
        • Phillips M.R.
        • et al.
        The global distribution of fatal pesticide self-poisoning: systematic review.
        BMC Public Health. 2007; 7: 357
        • Sam K.G.
        • Kondabolu K.
        • Pati D.
        • et al.
        Poisoning severity score, APACHE II and GCS: effective clinical indices for estimating severity and predicting outcome of acute organophosphorus and carbamate poisoning.
        J Forensic Leg Med. 2009; 16 ([Epub 2009 Jan 16]): 239-247
        • Kang E.J.
        • Seok S.J.
        • Lee K.H.
        • et al.
        Factors for determining survival in acute organophosphate poisoning.
        Korean J Intern Med. 2009; 24: 362-367
        • Chuang F.R.
        • Jang S.W.
        • Lin J.L.
        • et al.
        QTc prolongation indicates a poor prognosis in patients with organophosphate poisoning.
        Am J Emerg Med. 1996; 14: 451-453
        • Hanley M.J.
        • Abernethy D.R.
        • Greenblatt D.J.
        Effect of obesity on the pharmacokinetics of drugs in humans.
        Clin Pharmacokinet. 2010; 49: 71-87
        • Lim S.Y.
        • Kim S.I.
        • Ryu Y.J.
        • et al.
        The body mass index as a prognostic factor of critical care.
        Korean J Intern Med. 2010; 25 ([Epub 2010 Jun 1]): 162-167
        • Kelly T.
        • Yang W.
        • Chen C.S.
        • et al.
        Global burden of obesity in 2005 and projections to 2030.
        Int J Obes (Lond). 2008; 32 ([Epub 2008 Jul 8]): 1431-1437
        • Cheymol G.
        Effects of obesity on pharmacokinetics implications for drug therapy.
        Clin Pharmacokinet. 2000; 39: 215-231
        • Bearden D.T.
        • Rodvold K.A.
        Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
        Clin Pharmacokinet. 2000; 38: 415-426
        • Green B.
        • Duffull S.B.
        What is the best size descriptor to use for pharmacokinetic studies in the obese?.
        Br J Clin Pharmacol. 2004; 58: 119-133
        • Sakr Y.
        • Madl C.
        • Filipescu D.
        • et al.
        Obesity is associated with increased morbidity but not mortality in critically ill patients.
        Intensive Care Med. 2008; 34 ([Epub 2008 Aug 1]): 1999-2009
        • Akinnusi M.E.
        • Pineda L.A.
        • El Solh A.A.
        Effect of obesity on intensive care morbidity and mortality: a meta-analysis.
        Crit Care Med. 2008; 36: 151-158
        • Benfenati E.
        • Gini G.
        • Piclin N.
        • et al.
        Predicting log P of pesticides using different software.
        Chemosphere. 2003; 53: 1155-1164
        • Lee Y.E.
        • Park J.E.
        • Hwang J.Y.
        • et al.
        Comparison of health risks according to the obesity types based upon BMI and waist circumference in Korean adult: the 1998-2005 Korea National Health and Nutrition Examination Survey.
        Korean J Nutr. 2009; 42: 631-638
        • WHO Western Pacific Region
        The Asia-pacific perspective: refinding obesity and its treatment.
        2000
        • Aygun D.
        • Doganay Z.
        • Altintop L.
        • et al.
        Serum acetylcholinesterase and prognosis of acute organophosphate poisoning.
        J Toxicol Clin Toxicol. 2002; 40: 903-910
        • Hollenstein U.M.
        • Brunner M.
        • Schmid R.
        • et al.
        Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
        Int J Obes Relat Metab Disord. 2001; 25: 354-358
        • Katzung Bertgram G.
        Basic & clinical pharmacology.
        (International edition)10th ed. 2007 ([chapter I −3])
        • Trevor Anthony J.
        • Katzung
        • et al.
        Katzung & Trevor's pharmacology.
        7th ed. McGraw-Hill, 2007: 59
        • Cheymol G.
        Drug pharmacokinetics in the obese.
        Fundam Clin Pharmacol. 1988; 2: 239-256
        • Harvey R.A.
        • Champe P.C.
        Lippincott's illustrated reviews: pharmacology.
        4th ed. 2008
        • Dvorchik B.H.
        • Damphousse D.
        The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
        J Clin Pharmacol. 2005; 45: 48-56
        • Sparreboom A.
        • Wolff A.C.
        • Mathijssen R.H.
        • et al.
        Evaluation of alterate size descriptors for dose calculation of anticancer drugs in the obese.
        J Clin Oncol. 2007; 25: 4707-4713
        • Davies J.E.
        • Barquet A.
        • Freed V.H.
        • et al.
        Human pesticides poisonings by a fat soluble organophosphate pesticide.
        Arch Environ Health. 1975; 30: 608-613
        • Sakamato T.
        • Sawada Y.
        • Nishide K.
        • et al.
        Delayed neurotoxicity produced by an organophosphorus compound (sumithion). A case report.
        Arch Toxicol. 1984; 56: 136-138
        • Gerkin R.
        • Curry S.C.
        Persistently elevated plasma insecticides levels in severe methylparathion poisoning.
        Vet Hum Toxicol. 1987; 29: 483-484
        • Baron R.L.
        Carbamate insecticides.
        in: Hayes W.J. Laws E.R. Handbook of pesticide toxicology. Academic Press, San Diago, CA1991: 1125-1189